Scholarlink

<p>Recognizing the growing impact of sarcopenia among older adults in Iran, this study aimed to estimate its prevalence and quantify the population-attributable fraction (PAF) of potential risk factors using data from the Iranian Multicenter Osteoporosis Study (IMOS-2021). A total of 705 participants aged ≥ 60 years completed the IMOS examinations. Sarcopenia was defined as the coexistence of low muscle mass and low muscle strength, and severe sarcopenia as low muscle mass, low muscle strength, and low physical performance. Complex survey analysis was used to calculate the weighted prevalence, and multivariable Poisson regression models were applied to identify associated risk factors and subsequently, their PAFs. The mean age of participants was 67.2 years, and 50.4% were women. The weighted prevalence of sarcopenia was 13.8% (11.1–17.0%), increasing significantly with age (<i>P</i> for trend &lt; 0.001). A body mass index (BMI) &lt; 25 showed a strong association [APR = 5.80 (2.40–13.97)] and the highest PAF (51.0%) for sarcopenia, followed by high fat mass [APR = 2.31 (1.47–3.64); PAF = 42.39%]. Other possible contributing factors were low physical activity (PAF = 28.71%), and small calf circumference (PAF = 16.55%). Sarcopenia is relatively prevalent among Iranian older adults. Low BMI, high adiposity, and low physical activity are key modifiable targets, highlighting the need for prompt nationwide interventions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prevalence of sarcopenia and population attributable fraction of related factors in Iranian older adults from the IMOS‑2021 study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月3日

查看全文
  • Arash Ghazbani,
  • Amirhossein Aghakhani,
  • Kazem Khalagi,
  • Narges Zargar Balajam,
  • Mohammad Javad Mansourzadeh,
  • Mahnaz Sanjari,
  • Sepideh Hajivalizadeh,
  • Elahe Hesari,
  • Noushin Fahimfar,
  • Afshin Ostovar,
  • Ramin Heshmat,
  • Gita Shafiee

摘要

Recognizing the growing impact of sarcopenia among older adults in Iran, this study aimed to estimate its prevalence and quantify the population-attributable fraction (PAF) of potential risk factors using data from the Iranian Multicenter Osteoporosis Study (IMOS-2021). A total of 705 participants aged ≥ 60 years completed the IMOS examinations. Sarcopenia was defined as the coexistence of low muscle mass and low muscle strength, and severe sarcopenia as low muscle mass, low muscle strength, and low physical performance. Complex survey analysis was used to calculate the weighted prevalence, and multivariable Poisson regression models were applied to identify associated risk factors and subsequently, their PAFs. The mean age of participants was 67.2 years, and 50.4% were women. The weighted prevalence of sarcopenia was 13.8% (11.1–17.0%), increasing significantly with age (P for trend < 0.001). A body mass index (BMI) < 25 showed a strong association [APR = 5.80 (2.40–13.97)] and the highest PAF (51.0%) for sarcopenia, followed by high fat mass [APR = 2.31 (1.47–3.64); PAF = 42.39%]. Other possible contributing factors were low physical activity (PAF = 28.71%), and small calf circumference (PAF = 16.55%). Sarcopenia is relatively prevalent among Iranian older adults. Low BMI, high adiposity, and low physical activity are key modifiable targets, highlighting the need for prompt nationwide interventions.